SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001447028-22-000047
Filing Date
2022-08-04
Accepted
2022-08-04 16:08:21
Documents
60
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q abus-20220630.htm   iXBRL 10-Q 1326082
2 EX-31.1 a2022-q210xqex311.htm EX-31.1 10912
3 EX-31.2 a2022-q210xqex312.htm EX-31.2 10930
4 EX-32.1 a2022-q210xqex321.htm EX-32.1 4932
5 EX-32.2 a2022-q210xqex322.htm EX-32.2 4962
11 PIPELINE abus-20220630_g1.jpg GRAPHIC 65139
  Complete submission text file 0001447028-22-000047.txt   5925236

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT abus-20220630.xsd EX-101.SCH 40133
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT abus-20220630_cal.xml EX-101.CAL 47937
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT abus-20220630_def.xml EX-101.DEF 214739
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT abus-20220630_lab.xml EX-101.LAB 460692
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT abus-20220630_pre.xml EX-101.PRE 305160
54 EXTRACTED XBRL INSTANCE DOCUMENT abus-20220630_htm.xml XML 955985
Mailing Address 701 VETERANS CIRCLE WARMINSTER PA 18974
Business Address 701 VETERANS CIRCLE WARMINSTER PA 18974 604-419-3200
Arbutus Biopharma Corp (Filer) CIK: 0001447028 (see all company filings)

IRS No.: 980597776 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34949 | Film No.: 221136566
SIC: 2834 Pharmaceutical Preparations